Get started
Author

Faith Tierney

Observed name: F. Tierney
Observed institution: Columbia University
OpenAlex ID: A5030220341
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2021 · Gadi Lalazar, David Requena, et al. · Cancer Discovery · 47
PDF
Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Supplementary Table 3 from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Supplementary Figures and Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Supplementary Table 3 from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Supplementary Figures and Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Data from Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
2023 · Gadi Lalazar, David Requena, et al.
Transplant vs Resection for Intrahepatic Cholangiocarcinoma - Potential for Benefit with Transplant?
2021 · A. Mathur, F. Tierney, et al. · HPB
PDF
Works count: 8
Citation count: 47
H-index: 1
I10-index: 1
Year
Topic
Type